Anbio Biotechnology Class A Ordinary Shares

NNNN | NASDAQ

$5.62

-$0.06 (-1.06%)

Sep 22, 2026, 10:39 AM ET · Market open

TTM Period Ending	Q4 2025 Dec 30, 2025	Q2 2025 Jun 29, 2025	Q4 2024 Dec 30, 2024	Q2 2024 Jun 29, 2024	Q4 2023 Dec 30, 2023	Q2 2023 Jun 29, 2023
Revenue	9.74M	7.54M	8.85M	10.27M	7.26M	3.31M
Cost of Revenue	1.26M	774.89K	2.49M	4.35M	3.62M	1.36M
Gross Profit	8.48M	6.76M	6.36M	5.92M	3.63M	1.94M
Operating Income	6.48M	1.94M	2.15M	4.47M	2.12M	1.54M
Interest Income	155.25K	368.63K	365.13K	309.72K	178.82K	18.75K
Pretax Income	7.19M	2.82M	2.56M	4.68M	2.44M	1.64M
Net Income	7.19M	2.82M	2.56M	4.68M	2.44M	1.64M
Selling & General & Admin	1.78M	4.32M	3.72M	1.16M	1.37M	406.06K
Research & Development	225.05K	496.88K	491.49K	283.72K	145.7K	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.01M	4.82M	4.21M	1.45M	1.51M	406.06K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.27M	-2.93M	-6.7M	-5.8M	-5.14M	-1.77M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	43.89M	43.89M	42.29M	42.29M	42.29M	42.29M
Shares Outstanding (Diluted)	43.89M	43.89M	42.29M	42.29M	42.29M	42.29M
EPS (Basic)	0.16	0.06	0.06	0.11	0.06	0.04
EPS (Diluted)	0.16	0.06	0.06	0.11	0.06	0.04
EBITDA	6.95M	2.82M	2.56M	4.68M	2.45M	1.65M
EBIT	6.95M	2.82M	2.56M	4.68M	2.44M	1.64M
Depreciation & Amortization	n/a	n/a	n/a	3.54K	13.03K	9.49K